Independent agencies - 2020 edition
This list displays those agencies that told us they were not part of a larger network.
Click on an agency name or logo to view their profile page where you can read what the agency has to say about themselves, view the data they submitted and a breakdown of how their overall position is made up from the different ranking factors. Find out how the list was created and the methodology used here.
Rank | OverallRank | Name | Awards | Social media | Total agency billings | UK creative healthcare billings | Total staff | Healthcare staff | Age | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
32 | ARK Agency |
|
|
|
|
10-24 staff | 10-19 staff | 2-3 years | |||||||||
29 | Bedrock Group |
|
|
|
|
25-49 staff | 20-29 staff | Between 7 and 10 years | |||||||||
35 | bmore digital |
|
|
|
|
0-9 staff | 0-9 staff | Between 10 and 15 years | |||||||||
26 | Brandcast Health |
|
|
|
|
25-49 staff | 20-29 staff | Between 15 and 20 years | |||||||||
33 | Cuttsy+Cuttsy |
|
|
|
|
25-49 staff | 20-29 staff | Between 7 and 10 years | |||||||||
31 | Dice Medical Communications |
|
|
|
|
10-24 staff | 20-29 staff | Between 10 and 15 years | |||||||||
24 | earthware |
|
|
|
|
10-24 staff | 20-29 staff | Between 10 and 15 years | |||||||||
38 | Kanga Health Ltd |
|
|
|
|
25-49 staff | 40-49 staff | Between 7 and 10 years | |||||||||
30 | KVA |
|
|
|
|
25-49 staff | 40-49 staff | Between 7 and 10 years | |||||||||
25 | MJL |
|
|
|
|
10-24 staff | 20-29 staff | Over 30 years | |||||||||
20 | Oi Ltd |
|
|
|
|
50-74 staff | 50-74 staff | Between 20 and 30 years | |||||||||
39 | Page & Page and Partners |
|
|
|
|
10-24 staff | 10-19 staff | Between 5 and 7 years | |||||||||
15 | Purple Agency |
|
|
|
|
150-249 staff | 100-149 staff | Between 10 and 15 years | |||||||||
19 | Swordfish Advertising Ltd. |
|
|
|
|
25-49 staff | 30-39 staff | Between 15 and 20 years | |||||||||
27 | Verve |
|
|
|
|
10-24 staff | 10-19 staff | Between 7 and 10 years | |||||||||
17 | W2O Group |
|
|
|
|
150-249 staff | 100-149 staff | Between 10 and 15 years | |||||||||
34 | woolleypau |
|
|
|
|
10-24 staff | 10-19 staff | Between 20 and 30 years | |||||||||
40 | Wordbird |
|
|
|
|
10-24 staff | 0-9 staff | Between 7 and 10 years | |||||||||
16 | Lucid Group |
|
|
|
|
250-499 staff | 150 - 249 staff | Between 10 and 15 years | |||||||||
36 | CAN advertising Ltd |
|
|
|
|
10-24 staff | 10-19 staff | Between 10 and 15 years | |||||||||
21 | RFA Advertising & Marketing |
|
|
|
|
50-74 staff | 50-74 staff | Between 20 and 30 years |
This listing was produced in good faith using data supplied by the agencies and data in the public domain. Some data may not have been independently verified by PMLiVE. This is not an exhaustive list of all agencies working in the UK. Find out how the list was created and the methodology used here.
COVID-19 Updates and Daily News
Featured jobs
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
Quick links
Latest intelligence
- The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
- Recognising HIV Vaccine Awareness Day
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Scientists discover new approach to treat brain tumours
- Moderna wins Prix Galien UK Award for best biotechnology product
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Positive CHMP opinion issued for PTC Therapeutics’ Upstaza
- Live Webinar: The Future of MedTech: Streamlined Clinical Data Collection & Management
- Medscape: Connect to the conversation
- A Medscape 4-part video interview series